Patent intelligence · US
US 7241571
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
Patent details — US 7241571
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 10, 2007
- Expiration
- Jul 5, 2027
- Claims
- 3
- CPC classes
- A61P, A61P43/00, A61P7/06, A61P9/00
Quick answer
US 7241571 (Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis) is held by The Regents of the University of California. Status: granted. Granted Jul 10, 2007. Expires Jul 5, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61P, A61P43/00, A61P7/06, A61P9/00, A61P9/08, A61P9/10
More from The Regents of the University of California
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 7241571?
US 7241571 (Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis) is held by The Regents of the University of California. Status: granted. Granted Jul 10, 2007. Expires Jul 5, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7241571?
The Regents of the University of California is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 7241571 expire?
Our index shows an expiration date of Jul 5, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.